A new trading day began on Tuesday, with Vir Biotechnology Inc (NASDAQ: VIR) stock price down -3.91% from the previous day of trading, before settling in for the closing price of $9.47. VIR’s price has ranged from $6.56 to $14.45 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 532.77% over the past five years. Meanwhile, its annual earnings per share averaged 15.42%. With a float of $88.07 million, this company’s outstanding shares have now reached $136.71 million.
Let’s look at the performance matrix of the company that is accounted for 587 employees. In terms of profitability, gross margin is 81.92%, operating margin of -658.31%, and the pretax margin is -685.83%.
Vir Biotechnology Inc (VIR) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Vir Biotechnology Inc is 36.05%, while institutional ownership is 51.17%. The most recent insider transaction that took place on Feb 24 ’25, was worth 95,063. In this transaction Director of this company sold 10,056 shares at a rate of $9.45, taking the stock ownership to the 698,239 shares. Before that another transaction happened on Feb 24 ’25, when Company’s EVP & Chief Technology Officer sold 14,168 for $9.45, making the entire transaction worth $133,936. This insider now owns 117,901 shares in total.
Vir Biotechnology Inc (VIR) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 15.42% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.69% during the next five years compared to -34.12% drop over the previous five years of trading.
Vir Biotechnology Inc (NASDAQ: VIR) Trading Performance Indicators
Here are Vir Biotechnology Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 8.94. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 15.94.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.92, a number that is poised to hit -0.87 in the next quarter and is forecasted to reach -3.67 in one year’s time.
Technical Analysis of Vir Biotechnology Inc (VIR)
Vir Biotechnology Inc (NASDAQ: VIR) saw its 5-day average volume 0.9 million, a negative change from its year-to-date volume of 2.58 million. As of the previous 9 days, the stock’s Stochastic %D was 44.82%. Additionally, its Average True Range was 0.62.
During the past 100 days, Vir Biotechnology Inc’s (VIR) raw stochastic average was set at 32.19%, which indicates a significant increase from 14.21% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 45.38% in the past 14 days, which was lower than the 101.49% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.19, while its 200-day Moving Average is $8.90. Nevertheless, the first resistance level for the watch stands at $9.52 in the near term. At $9.95, the stock is likely to face the second major resistance level. The third major resistance level sits at $10.25. If the price goes on to break the first support level at $8.79, it is likely to go to the next support level at $8.49. The third support level lies at $8.06 if the price breaches the second support level.
Vir Biotechnology Inc (NASDAQ: VIR) Key Stats
With a market capitalization of 1.25 billion, the company has a total of 137,720K Shares Outstanding. Currently, annual sales are 86,180 K while annual income is -615,060 K. The company’s previous quarter sales were 2,380 K while its latest quarter income was -213,720 K.
